Hepatitis C virus infection in USA: An estimate of true prevalence

Liver International

Volumn 31, Issue 8, 2011, Pages 1090-1101

  Chak, Eric ^a   Talal, Andrew H ^b   Sherman, Kenneth E ^c   Schiff, Eugene R ^d   Saab, Sammy ^e  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis C virus; Prevalence

Indexed keywords

HEALTH CARE PERSONNEL; HEALTH SURVEY; HEMODIALYSIS; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HOMELESSNESS; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ABUSE; MEDICAID; MEDICARE; MEDLINE; NURSING HOME PERSONNEL; PRISON; RECIPIENT; REVIEW; SEROPREVALENCE; SYSTEMATIC REVIEW; UNITED STATES; VETERAN; VIRUS TRANSMISSION;

DRUG USERS; HEALTH PERSONNEL; HEALTH SURVEYS; HEPATITIS C; HOMELESS PERSONS; HUMANS; MILITARY PERSONNEL; NURSING HOMES; PREVALENCE; PRISONERS; RENAL DIALYSIS; RISK FACTORS; UNITED STATES; VETERANS; VULNERABLE POPULATIONS;

EID: 79961199944     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02494.x     Document Type: Review

References (99)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
3. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-46.
4. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-14.
5. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975; 292: 767-70.
6. Fox RK, Currie SL, Evans J, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005; 41: 177-86.
7. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health 2004; 81: 25-37.
8. Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 2004; 94: 1218-23.
9. Baillargeon J, Wu H, Kelley MJ, et al. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health 2003; 117: 43-8.
10. Ruiz JD, Molitor F, Sun RK, et al. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med 1999; 170: 156-60.
11. Spaulding A, Greene C, Davidson K, Schneidermann M, Rich J. Hepatitis C in state correctional facilities. Prev Med 1999; 28: 92-100.
12. Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993; 9: 566-9.
13. Beck A, Maruschak L. Hepatitis testing and treatment in state prisons, 2004. Available at (accessed 24 September 2010).
14. US Department of Housing and Urban Development. The Annual Homeless Assessment Report to Congress, 2009. Available at (accessed 21 August 2010).
15. Schwarz KB, Garrett B, Alter MJ, Thompson D, Strathdee SA. Seroprevalence of HCV infection in homeless Baltimore families. J Health Care Poor Underserved 2008; 19: 580-7.
16. Riley ED, Bangsberg DR, Guzman D, Perry S, Moss AR. Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco's homeless and marginally housed. J Acquir Immune Defic Syndr 2005; 38: 191-5.
17. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med 2004; 19: 357-65.
18. Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: a latent variable approach. Drug Alcohol Depend 2004; 75: 89-95.
19. Desai RA, Rosenheck RA, Agnello V. Prevalence of hepatitis C virus infection in a sample of homeless veterans. Soc Psychiatr Psychiatr Epidemiol 2003; 38: 396-401.
20. Klinkenberg WD, Caslyn RJ, Morse GA, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatr 2003; 44: 293-302.
21. Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol 2002; 34: 476-80.
22. Nyamathi AM, Dixon EL, Wiley D, Christiani A, Lowe A. Hepatitis C virus infection among homeless men referred from a community clinic. West J Nurs Res 2006; 28: 475-88.
23. Rosenblum A, Nuttbrock L, McQuistion HL, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis 2001; 20: 15-25.
24. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002; 36: S93-8.
25. Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000; 30: S77-84.
26. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34: 831-7.
27. van de Laar TJ, Matthews GV, Prins M, Danta M. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010; 24: 1799-812.
28. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 4: 1-39.
29. Diaz T, Des Jarlais DC, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001; 9: 23-30.
30. Thorpe LE, Ouellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis 2000; 182: 1588-94.
31. Amon JJ, Garfein RS, Ahdieh-Grant L, et al. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis 2008; 46: 1852-8.
32. Garfein RS, Swartzendruber A, Ouellet LJ, et al. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend 2007; 91: S4-17.
33. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86: 655-61.
34. Murrill CS, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 2002; 92: 385-7.
35. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002; 186: 1558-64.
36. Tseng FC, O'Brien TR, Zhang M, et al. Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology 2007; 46: 666-71.
37. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995; 74: 212-20.
38. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002; 155: 645-53.
39. Burt RD, Hagan H, Garfein RS, et al. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health 2007; 84: 436-54.
40. Hagan H, McGough JP, Thiede H, et al. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999; 149: 203-13.
41. Drug Users Intervention Trial (DUIT). Available at (accessed 21 August 2010).
42. Garfein RS, Golub ET, Greenberg AE, et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS 2007; 21: 1923-32.
43. Knittel AK, Wren PA, Gore L. Lessons learned from a peri-urban needle exchange. Harm Reduct J 2010; 7: 8.
44. Holtzman D, Barry V, Ouellet LJ, et al. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med 2009; 49: 68-73.
45. Centers for Disease Control and Prevention (CDC). Syringe exchange programs - United States, 2008. MMWR Morb Mortal Wkly Rep 2010; 59: 1488-91.
46. Martinez A, Talal AH. Noninjection drug use: an under-appreciated risk factor for hepatitis C virus transmission. Liver Int 2008; 28: 757-60.
47. Hermida M, Ferreiro MC, Barral S, et al. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test. J Virol Methods 2002; 101: 29-35.
48. Maticic M, Poljak M, Kramar B, et al. Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva. J Periodontol 2001; 72: 11-6.
49. McMahon JM, Simm M, Milano D, Clatts M. Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob 2004; 3: 6.
50. Scheinmann R, Hagan H, Lelutiu-Weinberger C, et al. Non-injection drug use and hepatitis C virus: a systematic review. Drug Alcohol Depend 2007; 89: 1-12.
51. Gershon RR, Sherman M, Mitchell C, et al. Prevalence and risk factors for bloodborne exposure and infection in correctional healthcare workers. Infect Control Hosp Epidemiol 2007; 28: 24-30.
52. Datta SD, Armstrong GL, Roome AJ, Alter MJ. Blood exposures and hepatitis C virus infections among emergency responders. Arch Intern Med 2003; 163: 2605-10.
53. Rischitelli G, McCauley L, Lambert WE, Lasarev M, Mahoney E. Hepatitis C in urban and rural public safety workers. J Occup Environ Med 2002; 44: 568-73.
54. Rischitelli G, McCauley L, Lambert WC. Hepatitis C screening and prevalence among urban and rural public safety workers in Oregon. J Occup Environ Med 2002; 44: 223-4.
55. Roome AJ, Hadler JL, Thomas AL, et al. Hepatitis C virus infection among firefighters, emergency medical technicians, and paramedics - selected locations, United States, 1991-2000. MMWR Morb Mortal Wkly Rep 2000; 49: 660-5.
56. Peate WF. Preventing needlesticks in emergency medical system workers. J Occup Environ Med 2001; 43: 554-7.
57. Upfal MJ, Naylor P, Mutchnick MM. Hepatitis C screening and prevalence among urban public safety workers. J Occup Environ Med 2001; 43: 402-11.
58. Werman HA, Gwinn R. Seroprevalence of hepatitis B and hepatitis C among rural emergency medical care personnel. Am J Emerg Med 1997; 15: 248-51.
59. Thomas DL, Gruninger SE, Siew C, Joy ED, Quinn TC. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med 1996; 100: 41-5.
60. Panlilio AL, Shapiro CN, Schable CA, et al. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. J Am Coll Surg 1995; 180: 16-24.
61. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994; 170: 1410-7.
62. Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993; 21: 196-200.
63. Klein RS, Freeman K, Taylor PE, Stevens CE. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991; 338: 1539-42.
64. Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 2005; 41: 88-96.
65. Roselle GA, Danko LH, Kralovic SM, Simbartl LA, Kizer KW. National Hepatitis C Surveillance Day in the Veterans Health Administration of the Department of Veterans Affairs. Mil Med 2002; 167: 756-9.
66. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 2000; 95: 740-7.
67. Himelhoch S, McCarthy JF, Ganoczy D, et al. Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis. Psychosomatics 2009; 50: 30-7.
68. Groom H, Dieperink E, Nelson DB, et al. Outcomes of a hepatitis C screening program at a large urban VA medical center. J Clin Gastroenterol 2008; 42: 97-106.
69. Kilbourne AM, McCarthy JF, Himelhoch S, et al. Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders. Gen Hosp Psychiatr 2008; 30: 495-500.
70. Mallette C, Flynn MA, Promrat K. Outcome of screening for hepatitis C virus infection based on risk factors. Am J Gastroenterol 2008; 103: 131-7.
71. Matthews AM, Huckans MS, Blackwell AD, Hauser P. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord 2008; 10: 266-70.
72. Goulet JL, Fultz SL, McGinnis KA, Justice AC. Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS 2005; 19: S99-105.
73. Mishra G, Sninsky C, Roswell R, Fitzwilliam S, Hyams KC. Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital. Dig Dis Sci 2003; 48: 815-20.
74. Brau N, Bini EJ, Shahidi A, et al. Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area. Am J Gastroenterol 2002; 97: 2071-8.
75. Briggs ME, Baker C, Hall R, et al. Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology 2001; 34: 1200-5.
76. Austin GE, Jensen B, Leete J, et al. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans. Am J Med Sci 2000; 319: 353-9.
77. Seeff LB, Miller RN, Rabkin CS, et al. 45-Year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132: 105-11.
78. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001; 50: 1-43.
79. Alter HJ, Houghton M. Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med 2000; 6: 1082-6.
80. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18: 52-61.
81. Kumar A, Kulkarni R, Murray DL, et al. Serologic markers of viral hepatitis A, B, C, and D in patients with hemophilia. J Med Virol 1993; 41: 205-9.
82. Troisi CL, Hollinger FB, Hoots WK, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993; 81: 412-8.
83. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 1990; 76: 254-6.
84. Hyams KC, Riddle J, Rubertone M, et al. Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21, 000 troops. Am J Epidemiol 2001; 153: 764-70.
85. Chien NT, Dundoo G, Horani MH, et al. Seroprevalence of viral hepatitis in an older nursing home population. J Am Geriatr Soc 1999; 47: 1110-3.
86. Lanphear BP, Linnemann CC, Jr, Cannon CG, et al. Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994; 15: 745-50.
87. Kelen GD, Green GB, Purcell RH, et al. Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 1992; 326: 1399-404.
88. Brillman JC, Crandall CS, Florence CS, Jacobs JL. Prevalence and risk factors associated with hepatitis C in ED patients. Am J Emerg Med 2002; 20: 476-80.
89. Hall MR, Ray D, Payne JA. Prevalence of hepatitis C, hepatitis B, and human immunodeficiency virus in a Grand Rapids, Michigan emergency department. J Emerg Med 2010; 38: 401-5.
90. Meyer JM. Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: results from Oregon State Hospital. J Clin Psychiatr 2003; 64: 540-5.
91. Center for Disease Control. Summary of notifiable diseases, United States, 2007. Morb Mortal Wkly Rep 2009; 56: 1-100.
92. Center for Disease Control (CDC). Hemophilia. Available at (accessed 21 August 2010).
93. Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999; 29: 1311-6.
94. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003; 9: 331-8.
95. Nyamathi AM, Dixon EL, Robbins W, et al. Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med 2002; 17: 134-43.
96. US Department of Justice. Prisoners at Yearend 2009 - Advance Counts. Available at (accessed 21 August 2010).
97. US Census Bureau. 2006-2008 American Community Survey. Available at -bm=y&-geo-id=01000US&-qr-name=ACS-2008-3YR-G00-S2101&-ds-name=ACS-2008-3YR-G00-&-redoLog=false (accessed 21 August 2010).
98. US Department of Defense. Active Duty Military Personnel Strengths by Regional Area and by Country (309A), 30 June 2009. Available at (accessed 21 August 2010).
99. US Department of Labor. Occupational Employment and Wages - May 2009. Available at (accessed 21 August 2010).